Journal of Clinical and Experimental Hepatology

Scope & Guideline

Innovating hepatology: where clinical practice meets scientific discovery.

Introduction

Explore the comprehensive scope of Journal of Clinical and Experimental Hepatology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Journal of Clinical and Experimental Hepatology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0973-6883
PublisherELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTD
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2011 to 2025
AbbreviationJ CLIN EXP HEPATOL / J. Clin. Exp. Hepatol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address17-A/1 MAIN RING ROAD, LAJPAT NAGAR IV, NEW DELHI 110024, INDIA

Aims and Scopes

The Journal of Clinical and Experimental Hepatology aims to provide a comprehensive platform for the dissemination of research related to liver diseases and hepatology. The journal focuses on various aspects of hepatology, including clinical practices, experimental studies, and advancements in liver transplantation and disease management.
  1. Clinical Research on Liver Diseases:
    The journal emphasizes clinical studies that investigate the epidemiology, diagnosis, and management of liver diseases such as Hepatitis, Non-alcoholic Fatty Liver Disease (NAFLD), and Hepatocellular Carcinoma (HCC).
  2. Transplantation Studies:
    There is a strong focus on liver transplantation, including donor evaluation, transplantation techniques, surgical outcomes, and post-transplant complications.
  3. Innovative Therapies and Biomarkers:
    The journal includes research on emerging therapies, drug efficacy, and the identification of novel biomarkers for liver diseases, particularly in the context of personalized medicine.
  4. Interventional Procedures:
    Papers discussing various interventional procedures, including endoscopic and radiological techniques for managing liver diseases, are a core part of the journal’s scope.
  5. Public Health and Epidemiology:
    The journal addresses the public health implications of liver diseases, exploring epidemiological trends and health policies that affect liver health.
  6. Basic and Translational Research:
    It also covers experimental studies that provide insights into the pathophysiology of liver diseases, facilitating the translation of basic research findings into clinical applications.
The Journal of Clinical and Experimental Hepatology is witnessing several emerging themes and trends that reflect the dynamic nature of research in hepatology. These trends highlight the evolving landscape of liver disease management and the integration of new technologies and methodologies.
  1. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD):
    Recent publications indicate a growing focus on MAFLD, reflecting a shift from traditional NAFLD terminology and emphasizing the metabolic aspects of liver disease.
  2. Advancements in Liver Transplantation Techniques:
    There is an increasing number of studies exploring innovative techniques in liver transplantation, including living donor transplantation and the use of machine perfusion.
  3. Artificial Intelligence and Machine Learning:
    The application of AI and machine learning in diagnostic processes and treatment personalization is emerging as a significant trend, with several studies exploring its potential in hepatology.
  4. Interventions in Hepatic Encephalopathy:
    Research on new interventions for managing hepatic encephalopathy is trending, particularly studies examining dietary modifications and pharmacological approaches.
  5. Public Health Initiatives and Screening Programs:
    There is a notable increase in research focused on public health strategies, including screening and early intervention programs for high-risk populations, particularly for viral hepatitis.
  6. Patient-Centric Outcomes and Quality of Life Assessments:
    Studies investigating the impact of liver diseases on patients' quality of life and health-related outcomes are gaining prominence, reflecting a more holistic view of patient care.

Declining or Waning

While the Journal of Clinical and Experimental Hepatology has robust coverage of various hepatological topics, certain areas appear to be declining in prominence based on recent publication trends. This may reflect shifts in research focus or evolving clinical priorities within the field.
  1. Traditional Pharmacological Therapies:
    There has been a noticeable decline in papers focused solely on traditional pharmacological treatments for liver diseases, possibly due to the rise of novel therapies and personalized medicine approaches.
  2. Single-Center Studies:
    The prevalence of single-center studies appears to be waning as the journal increasingly emphasizes multicenter trials and large cohort studies that provide more generalizable data.
  3. Basic Science without Clinical Application:
    Research that does not connect basic science findings to clinical applications is becoming less common, indicating a shift towards studies that demonstrate direct relevance to patient care.
  4. Outdated Diagnostic Techniques:
    There seems to be a reduction in studies focusing on older diagnostic methods, as newer, more effective technologies gain traction in the field.
  5. Secondary Liver Diseases:
    Topics related to secondary liver diseases, such as those caused by less common infectious agents or rare genetic conditions, are becoming less frequent, likely overshadowed by more prevalent conditions.

Similar Journals

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Connecting researchers and clinicians for better outcomes.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

DIGESTIVE AND LIVER DISEASE

Pioneering insights for a healthier tomorrow.
Publisher: ELSEVIER SCIENCE INCISSN: 1590-8658Frequency: 12 issues/year

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

LIVER TRANSPLANTATION

Pioneering Research in Hepatology and Transplantation.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1527-6465Frequency: 12 issues/year

LIVER TRANSPLANTATION, published by Lippincott Williams & Wilkins, stands at the forefront of hepatology and transplantation research, with a prestigious Q1 rating across the categories of Hepatology, Surgery, and Transplantation as of 2023. Since its inception in 2000, this journal has been dedicated to disseminating high-quality, cutting-edge research that advances the understanding and practice of liver transplantation. With an impressive ranking of 23rd out of 551 in Surgery and 9th out of 54 in Transplantation, it occupies an esteemed position in the academic landscape, attracting contributions from leading experts in the field. The journal's rigorous peer-review process ensures the publication of impactful studies, innovative clinical practices, and vital insights into patient management. By fostering a collaborative environment for researchers, clinicians, and students alike, LIVER TRANSPLANTATION serves as an essential resource for those engaged in the complexities of liver transplantation and related fields. Join the community committed to advancing liver health and transplantation science.

Saudi Journal of Gastroenterology

Championing open access to vital gastroenterological findings.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-3767Frequency: 6 issues/year

The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.

JHEP Reports

Empowering global health through accessible scholarship.
Publisher: ELSEVIERISSN: Frequency: 6 issues/year

JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.

Hepatology Communications

Fostering collaboration for a healthier liver future.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

Hepatology Communications, published by Lippincott Williams & Wilkins, serves as a pioneering platform in the field of hepatology, dedicated to advancing the understanding of liver diseases and treatments. Since its inception in 2017, this open access journal has rapidly gained recognition, achieving an impressive Q1 ranking in Hepatology as of 2023, and appealing to a diverse audience of researchers, clinicians, and students alike. With its focus on high-quality research and clinical studies, the journal aims to facilitate impactful discussions and disseminate vital findings that address the challenges faced in liver health. Operating out of the United States, and accessible globally, Hepatology Communications is committed to fostering a collaborative research environment and enhancing the visibility of scholarly work in hepatology, ultimately driving forward innovations in patient care and treatment strategies.

Clinical and Molecular Hepatology

Empowering global knowledge exchange in liver research.
Publisher: KOREAN ASSOC STUDY LIVERISSN: 2287-2728Frequency: 4 issues/year

Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Empowering Knowledge in Gastrointestinal and Liver Physiology
Publisher: AMER PHYSIOLOGICAL SOCISSN: 0193-1857Frequency: 12 issues/year

American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society, stands as a leading journal in the domains of gastroenterology, hepatology, and overall physiology. With an impressive impact factor and consistent ranking in the Q1 quartile across multiple categories, this journal provides a vital platform for disseminating advanced research and innovative findings related to gastrointestinal and liver physiology. Since its inception in 1980, the journal has fostered a community of researchers and clinicians dedicated to understanding and improving digestive and liver health. While maintaining a traditional subscription model, it ensures high-quality peer-reviewed content that is crucial for informed professional practice and academic inquiry. The journal’s Scopus ranks highlight its significant impact in the fields of gastroenterology and hepatology, making it an indispensable resource for academics and practitioners alike, eagerly exploring both foundational and cutting-edge topics in physiology.

HEPATOLOGY

Championing excellence in liver research since 1981.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0270-9139Frequency: 12 issues/year

HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Pioneering research for a healthier digestive future.
Publisher: WILEYISSN: 0815-9319Frequency: 12 issues/year

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.